Oskar Hansson
31 – 40 of 565
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Effects of certain pre-analytical factors on the performance of plasma phospho-tau217
(
- Contribution to journal › Article
-
Mark
Highly Accurate Blood Test for Alzheimer's Disease Comparable or Superior to Clinical CSF Tests
2024) In Nature Medicine(
- Contribution to journal › Article
-
Mark
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden
(
- Contribution to journal › Article
-
Mark
Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly
(
- Contribution to journal › Article
-
Mark
Fixel-Based Analysis Reveals Tau-Related White Matter Changes in Early Stages of Alzheimer’s Disease
(
- Contribution to journal › Article
-
Mark
Divergent functional connectivity changes associated with white matter hyperintensities
(
- Contribution to journal › Article
-
Mark
Blodtest – fönster till hjärnan vid Alzheimers sjukdom
(
- Contribution to journal › Scientific review
-
Mark
Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns
(
- Contribution to journal › Article
-
Mark
Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
In vivo detection of Alzheimer's and Lewy body disease concurrence : Clinical implications and future perspectives
(
- Contribution to journal › Scientific review